Lucky, Im with you on this one, 3 years and counting. Interesting thought I had after listening to the Streets
Adam Feuerstein this morning stating the he believes the outcome of the data will be positive, which was already known he reconfirmed this in the clip and stated so after speaking with a contingent of short sellers.
This would give him a first hand look at the reasoning the shorts are betting against positive data. As an investor in Ziopharm I would think this is somewhat positive in my view.
Funny how Adam F published the bear thesis so close to the release of data, I gather he spoke with the mystery short on Wednesday, two things I've noticed about Adam the kid got balls and don't give
a dam, Boston must be rubbing off on him.
I am hopeful since they initiated another large trial with Pali(SCLC) last year and just launched two additional trials in testiculat and breast cancer. Someone is seeing something positive. I think we clear the 3 month bar and maybe a little extra with a very clean safety profile. That is enough for partnering and approval. IFOS is a very bad drug. Hopefully Pali replaces it accross the board.